WAVEMAN · COMPANY

AURX · Nuo Therapeutics, Inc.

LIVE

TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475

← ALL COMPANIES

AURX

Name: Nuo Therapeutics, Inc. (AURX) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

Nuo Therapeutics, Inc.

MEDICAL DEVICES · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · CIK 0001091596

C-SUITE BUYING · 1☆ WATCH

INSIDER NET · 180D

$9.5K

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

13F, latest reported quarter

REVENUE GROWTH

+142.7%

XBRL, annual

NET MARGIN

-75.8%

CONVERSIONS · 180D

codes C/M, not in net · $242.5K priced

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

net +$9.5K over 180 days

+$9.5K over 90 days

more than 72% of Medical Devices

CONGRESS

no member of Congress has reported trading it

FUNDS

fewer than five institutions report holding it

REVENUE

+142.7% year over year

more than 96% of Medical Devices

MARGIN

-75.8% net margin

below 80% of Medical Devices

BUYBACKS

no share repurchases reported

SHORT

<0.1% of shares outstanding short · 1.0 days to cover · settled 2026-07-31

the lowest in Medical Devices

The year, with the filings on it

Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail

TOTAL 12M RETURN -30.8%

-30.8%12M

INSIDER BUYINSIDER SELL

INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

Insiders are net buyers of their own stock.

The record shows a net $9.5K bought by insiders over 180 days. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

TMO PEN ROK BLFS MTD SIBN WRBY ISRG TXG DXCM EW TMDX

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, Nuo Therapeutics, Inc. insiders bought a net $9.5K of stock across 17 Form 4 purchases and sales, with 1 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER

FILED

VALUE

JORDEN DAVID EMERSON

CEO/CFO

BUY

2026-08-28

7,984.0

$8.7K

JORDEN DAVID EMERSON

CEO/CFO

BUY

2026-08-27

789.0

$844

JORDEN DAVID EMERSON

CEO/CFO

SELL

2025-11-28

200,000.0

$300.0K

SHEEDY CHARLES E

—

BUY

2025-07-30

133,333.0

$200.0K

SHEEDY CHARLES E

—

BUY

2024-09-18

125,000.0

$93.8K

17 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 12 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

Ancora Advisors LLC

4,700.0 sh

$4.3K

SCHEDULE 13D/G

No 5%+ ownership filings

Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.

FORM 144

No planned-sale notices

No insider has notified an intent to sell. This is the panel to watch after a run-up.

Fundamentals

Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all

	2025-12	2024-12	2023-12	2022-12
REVENUE	$3.3M	$1.4M	$608.5K	$112.2K
GROSS PROFIT	$2.2M	$1.1M	$482.4K	$93.0K
OPERATING INCOME	$-2.5M	$-2.5M	$-3.2M	$-3.3M
NET INCOME	$-2.5M	$-2.3M	$-3.2M	$-3.2M
OPERATING CASH FLOW	$-865.0K	$-2.2M	$-3.2M	$-3.7M
CASH	$548.9K	$283.7K	$928.7K	$2.1M

SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE